Pioneering mRNA Cell Therapy for
autoimmune diseases
Pioneering RNA Cell Therapy for autoimmune diseases
Our Commitment to our Patients
We are committed to developing potent yet safer cell therapies for patients with autoimmune diseases.
Our therapeutic candidates
We are conducting clinical trials in patients with autoimmune diseases.
Our team
We are an integrated team of physicians and scientists working to develop the safest, most effective mRNA cell therapies for our patients.
Stay up to date on Cartesian
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
Proposals approved at Company’s special meeting of stockholders held March 27, 2024 GAITHERSBURG, MD, March 28, 2024 – Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”),…